Literature DB >> 30655901

Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13).

Hiroshi Kunikane1, Isao Yokota2, Nobuyuki Katakami3, Koji Takeda4, Koichi Takayama5, Toshiyuki Sawa6, Hiroshi Saito7, Masao Harada8, Soichiro Yokota9, Kiyoshi Ando10, Yuko Saito11, Yasuo Ohashi12, Kenji Eguchi13.   

Abstract

A prospective study has previously reported on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients with advanced lung cancer. The aim of the present study was to prospectively investigate how the quality of life (QOL) of patients with advanced lung cancer was affected by SREs. Patients with stage IIIB or IV non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) at any stage were followed up every four weeks to determine if they had developed SREs. QOL questionnaires were conducted at enrollment, at 3- and 12-months later and at 1 month after the onset of SREs, using QOL scores including the EuroQOL-5 Dimension (EQ-5D), Functional Assessment of Cancer Therapy-General (FACT-G) and activities of daily living (ADL) scores obtained by the Barthel Index. A total of 274 patients were enrolled in the study. At enrollment the EQ-5D and Barthel Index scores were lower in patients with SREs compared with patients without SREs. A chronological analysis revealed no statistically significant changes in either QOL or ADL in any of the patients. For 14 patients in whom QOL data was collected following the onset of SREs, the evaluation undertaken on the four subscales of the FACT-G revealed a significant decline in emotional functioning following the onset of SREs.

Entities:  

Keywords:  EuroQOL-5 dimension; barthel index; functional assessment of cancer therapy-general; lung cancer; quality of life; skeletal-related event

Year:  2018        PMID: 30655901      PMCID: PMC6312953          DOI: 10.3892/ol.2018.9680

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  5 in total

1.  Factors related to the quality of life in patients with bone metastases.

Authors:  Yusuke Shinoda; Ryoko Sawada; Futaba Yoshikawa; Takahiro Oki; Toshihide Hirai; Hiroshi Kobayashi; Ko Matsudaira; Hiroyuki Oka; Sakae Tanaka; Hirotaka Kawano; Nobuhiko Haga
Journal:  Clin Exp Metastasis       Date:  2019-07-18       Impact factor: 5.150

2.  Effectiveness of Rehabilitation for Cancer Patients with Bone Metastasis.

Authors:  Maki Itokazu; Yuji Higashimoto; Masami Ueda; Kazushi Hanada; Saori Murakami; Kanji Fukuda
Journal:  Prog Rehabil Med       Date:  2022-05-18

3.  Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents.

Authors:  Go Saito; Takahiro Ebata; Tsukasa Ishiwata; Shunichiro Iwasawa; Ichiro Yoshino; Yuichi Takiguchi; Koichiro Tatsumi
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.359

4.  miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44.

Authors:  Peng Zou; Menghai Zhu; Chong Lian; Jiaqiang Wang; Zhiquan Chen; Xiaoming Zhang; Yongchao Yang; Xinfeng Chen; Xinhui Cui; Jijun Liu; Hexuan Wang; Qi Wen; Ji Yi
Journal:  Sci Rep       Date:  2019-12-23       Impact factor: 4.379

5.  Assessment of Bone Health Education in US Multiple Myeloma and Solid Tumor Patients at Risk for Skeletal-Related Events.

Authors:  Darcy R Flora; Katherine B Carlson; David C Fuehrer; Benoit Cadieux; Guy Boike; Jennifer Schenfeld; Kimberly A Lowe
Journal:  Cancer Manag Res       Date:  2021-04-23       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.